nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cirrhotic cardiomyopathy: comprehensive insights into pathophysiology, diagnosis, and management
|
Ndakotsu, Andrew |
|
|
30 |
4 |
p. 739-748 |
artikel |
2 |
Correction to: Worsening heart failure: progress, pitfalls, and perspectives
|
Fonseca, Cândida |
|
|
30 |
4 |
p. 817-818 |
artikel |
3 |
Electronic health record nudges to optimize guideline-directed medical therapy for heart failure
|
Fuery, Michael A. |
|
|
30 |
4 |
p. 771-776 |
artikel |
4 |
Emerging, novel gene-modulating therapies for transthyretin amyloid cardiomyopathy
|
Ang, Song Peng |
|
|
30 |
4 |
p. 759-770 |
artikel |
5 |
Harnessing the lymphatic system
|
Ponikowska, Barbara |
|
|
30 |
4 |
p. 673-683 |
artikel |
6 |
Heart and brain interactions in heart failure: pathophysiological mechanisms and clinical perspectives
|
Liori, Sotiria |
|
|
30 |
4 |
p. 791-800 |
artikel |
7 |
Heart failure with preserved ejection fraction and atrial fibrillation: epidemiology, pathophysiology, and diagnosis interplay
|
Kittipibul, Veraprapas |
|
|
30 |
4 |
p. 697-705 |
artikel |
8 |
Left atrial shunting devices: why, what, how, and… when?
|
De Lorenzo, Leila Anna |
|
|
30 |
4 |
p. 685-696 |
artikel |
9 |
Leptin and heart failure: the chicken or the egg?
|
Theodorakis, Nikolaos |
|
|
30 |
4 |
p. 749-757 |
artikel |
10 |
Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities
|
Vacca, Antonio |
|
|
30 |
4 |
p. 637-655 |
artikel |
11 |
Mechanisms of exercise intolerance in heart failure with preserved ejection fraction (HFpEF)
|
Pecchia, Brandon |
|
|
30 |
4 |
p. 777-789 |
artikel |
12 |
Myeloperoxidase inhibition in the landscape of anti-inflammatory therapies for heart failure with preserved ejection fraction: the ENDEAVOR trial
|
Kittipibul, Veraprapas |
|
|
30 |
4 |
p. 735-738 |
artikel |
13 |
Noninvasive biometric monitoring technologies for patients with heart failure
|
Arriola-Montenegro, Jose |
|
|
30 |
4 |
p. 657-672 |
artikel |
14 |
Renal denervation in the setting of heart failure
|
Koppe-Schmeißer, Franziska |
|
|
30 |
4 |
p. 707-714 |
artikel |
15 |
Semaglutide in heart failure and atherosclerotic cardiovascular disease: the current state-of-the-art
|
Theodorakis, Nikolaos |
|
|
30 |
4 |
p. 801-816 |
artikel |
16 |
Worsening heart failure: progress, pitfalls, and perspectives
|
Fonseca, Cândida |
|
|
30 |
4 |
p. 715-734 |
artikel |